0 items USD 0.00Search
Your search for "mrrpb5 global robo taxi market size status forecast 2019 2025" gave back 33305 results.
A drug used to treat infections caused by staphylococci Market Analysis and Insights: Global Staphylococcal Infection Treatment Market The global...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Developmental and Epileptic Encephalopathies (DEE) consists of several types of severe brain disorders in which the epileptic electrical discharges...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Atriance market was valued at US$ 56 million in 2023 and is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A co-oximeter is a blood gas analyzer that, in addition to the status of gas tensions provided by traditional blood gas measurements, measures...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Arranon market was valued at US$ 79 million in 2023 and is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Nelarabine market was valued at US$ 134 million in 2023 and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
